MGO ONE SEVEN LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
MGO ONE SEVEN LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$3,250,535
-2.1%
31,912
-3.1%
0.25%
-17.8%
Q2 2023$3,321,633
+5.5%
32,917
-3.8%
0.30%
+52.0%
Q1 2023$3,148,028
+5.3%
34,218
+3.8%
0.20%
-33.1%
Q4 2022$2,989,690
-25.8%
32,955
+6.3%
0.30%
+91.7%
Q3 2022$4,030,000
+71.1%
30,990
+11.2%
0.16%
-52.0%
Q2 2022$2,356,000
-3.9%
27,872
-14.4%
0.32%
+23.6%
Q1 2022$2,451,000
-1.0%
32,558
-1.1%
0.26%
+2.3%
Q4 2021$2,475,000
+1.6%
32,930
-3.3%
0.26%
-16.8%
Q3 2021$2,436,000
-9.9%
34,063
-0.6%
0.31%
-18.3%
Q2 2021$2,704,000
+6.5%
34,264
-0.2%
0.38%
-13.3%
Q1 2021$2,538,000
-27.4%
34,323
-17.6%
0.44%
-39.5%
Q4 2020$3,497,000
+5.2%
41,661
-2.8%
0.72%
-8.7%
Q3 2020$3,325,000
-7.4%
42,870
-6.3%
0.79%
-15.3%
Q2 2020$3,592,000
+6.6%
45,755
+11.9%
0.93%
-18.5%
Q1 2020$3,370,000
-12.4%
40,873
+0.6%
1.14%
+13.9%
Q4 2019$3,846,000
+15.0%
40,619
+5.6%
1.00%
+4.6%
Q3 2019$3,343,000
+2.7%
38,465
+7.9%
0.96%
-8.6%
Q2 2019$3,256,000
+18.7%
35,662
+25.0%
1.05%
+17.6%
Q1 2019$2,743,000
+122.6%
28,538
+98.5%
0.89%
+69.3%
Q4 2018$1,232,000
+8.5%
14,377
+9.0%
0.53%
-0.6%
Q3 2018$1,136,000
+11.3%
13,191
+4.4%
0.53%
+13.0%
Q1 2018$1,021,000
-10.3%
12,631
-6.8%
0.47%
-10.6%
Q4 2017$1,138,00013,5510.53%
Other shareholders
NOVARTIS A G shareholders Q4 2021
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders